Literature DB >> 8597739

The interface between self medication and the NHS.

D H Thomas1, P R Noyce.   

Abstract

Cost and convenience seem to be major factors in determining whether, given the choice, patients purchase a medicine over the counter or obtain it on prescription. With current arrangements, exemption from prescription charges provides an incentive to continue to obtain products on NHS prescription even when they are available over the counter. There is therefore no simple relation between the availability of over the counter medicines and the level of prescribing of deregulated products. The appropriate use of over the counter medicines--particularly those that have only recently been deregulated--places a burden of care on community pharmacists and calls for closer working relationships with general practitioners. In particular, systems for referral and for recording details of both prescribed and over the counter medicines need to be developed, and a direct route needs to be established for community pharmacists to report adverse drug reactions to over the counter products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8597739      PMCID: PMC2350545          DOI: 10.1136/bmj.312.7032.688

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  Using a notification card to improve communication between community pharmacists and general practitioners.

Authors:  A Blenkinsopp; M Jepson; M Drury
Journal:  Br J Gen Pract       Date:  1991-03       Impact factor: 5.386

2.  Costs and benefits in switching from Rx to OTC.

Authors:  P Temin
Journal:  J Health Econ       Date:  1983-12       Impact factor: 3.883

3.  The creeping privatisation of NHS prescribing.

Authors:  I Heath
Journal:  BMJ       Date:  1994-09-10

4.  Privatisation of NHS prescribing.

Authors:  S Head
Journal:  BMJ       Date:  1994-10-08
  4 in total
  11 in total

1.  Managing demand: transfer of management of self limiting conditions from general practice to community pharmacies.

Authors:  K Hassell; Z Whittington; J Cantrill; F Bates; A Rogers; P Noyce
Journal:  BMJ       Date:  2001-07-21

2.  Monitoring safety of over the counter drugs. Patients could do more than just treat themselves.

Authors:  Alan G Wade
Journal:  BMJ       Date:  2002-02-16

3.  Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports.

Authors:  D Clark; D Layton; S A Shakir
Journal:  BMJ       Date:  2001-09-29

4.  Over the counter drugs. GPs' rate of recommending over the counter drugs varies.

Authors:  C Bradley; J Kenkre; R Tobias; D Dassu; A Riaz
Journal:  BMJ       Date:  1996-07-13

5.  Over the counter drugs. Telematics will be useful in providing information.

Authors:  F Sanz; M I Loza; E D Ahlgrimm; P Baetens; M Sosa-Iudicissa
Journal:  BMJ       Date:  1996-07-13

6.  Over-the-counter drugs and prescribing in general practice.

Authors:  D L Baines; D K Whynes
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

7.  Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues.

Authors:  H K Sinclair; C M Bond; P C Hannaford
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

8.  Sociodemographic factors related to self-medication in Spain.

Authors:  A Figueiras; F Caamaño; J J Gestal-Otero
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

9.  American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.

Authors:  P McElduff; M Jaefarnezhad; P N Durrington
Journal:  Heart       Date:  2006-05-22       Impact factor: 5.994

10.  Teaching and counselling behaviour: an applied study with community pharmacists.

Authors:  L Leemans; G Laekman
Journal:  Pharm World Sci       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.